Pseudomonas aeruginosa: new insights into pathogenesis and host defenses (Q38101888)

28 August 2017

Pseudomonas aeruginosa: new insights into pathogenesis and host defenses (English)

1 reference

28 August 2017

0 references

Pseudomonas aeruginosa

0 references

Shaan L Gellatly

1

0 references

Robert E. W. Hancock

series ordinal

2

object named as

Robert E W Hancock

1 reference

28 August 2017

15 March 2013

1 reference

28 August 2017

Pathogens and disease

1 reference

28 August 2017

67

1 reference

28 August 2017

3

1 reference

28 August 2017

159-173

1 reference

Therapeutic potential of host defense peptides in antibiotic-resistant infections

28 August 2017

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas evades immune recognition of flagellin in both mammals and plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Atypical activation of the unfolded protein response in cystic fibrosis airway cells contributes to p38 MAPK-mediated innate immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa: all roads lead to resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pulmonary surfactant: an immunological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Cystic fibrosis: a mucosal immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Iron uptake and metabolism in pseudomonads

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Type IV pilus structure and bacterial pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Bacterial quorum sensing in pathogenic relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Quorum sensing and Bacterial Pathogenicity: From Molecules to Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Antimicrobial peptides in defence of the oral and respiratory tracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Neutrophils in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

DNA adduct formation in the human nasal mucosa as a biomarker of exposure to environmental mutagens and carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Effects of Cl2MDP-encapsulating liposomes in a murine model of Pseudomonas aeruginosa-induced sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Structural classification of bacterial response regulators: diversity of output domains and domain combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The Pseudomonas aeruginosa PhoP-PhoQ two-component regulatory system is induced upon interaction with epithelial cells and controls cytotoxicity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Evolving concepts in biofilm infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Modulating immunity as a therapy for bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The type III secretion system of Pseudomonas aeruginosa: infection by injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The cystic fibrosis neutrophil: a specialized yet potentially defective cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Quinolones: from antibiotics to autoinducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Regulation of immunological homeostasis in the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The impact of COPD on lung health worldwide: epidemiology and incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The multiple signaling systems regulating virulence in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Biofilm dispersal: mechanisms, clinical implications, and potential therapeutic uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Targeting mechanisms of Pseudomonas aeruginosa pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The airway epithelium: structural and functional properties in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Mucus clearance as a primary innate defense mechanism for mammalian airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The role of pyocyanin in Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa OxyR is required for full virulence in rodent and insect models of infection and for resistance to human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Mechanical robustness of Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Mechanisms of biofilm resistance to antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa elastase degrades surfactant proteins A and D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Dynamics of Pseudomonas aeruginosa genome evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Role of bacterial proteases in pseudomonal and serratial keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Cationic antimicrobial peptides activate a two‐component regulatory system, PmrA‐PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Molecular comparison of a nonhemolytic and a hemolytic phospholipase C from Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The role played by contaminated surfaces in the transmission of nosocomial pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Inflammation, chronic obstructive pulmonary disease and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Role of polysaccharides in Pseudomonas aeruginosa biofilm development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pathogen-host interactions in Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas genomes: diverse and adaptable

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Two-component and phosphorelay signal-transduction systems as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Two-component signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa - a phenomenon of bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Molecular basis of reduced potency of underacylated endotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa virulence and therapy: evolving translational strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The Pseudomonas aeruginosa oxidative stress regulator OxyR influences production of pyocyanin and rhamnolipids: protective role of pyocyanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Clustering of Pseudomonas aeruginosa transcriptomes from planktonic cultures, developing and mature biofilms reveals distinct expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Intrinsic and innate defenses in the lung: intersection of pathways regulating lung morphogenesis, host defense, and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa: host defence in lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa Genome Database and PseudoCAP: facilitating community-based, continually updated, genome annotation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas exotoxin A: from virulence factor to anti-cancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Transcriptional regulation of the Pseudomonas aeruginosa type III secretion system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

Swarming of Pseudomonas aeruginosa is controlled by a broad spectrum of transcriptional regulators, including MetR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F2049-632X.12033

21 January 2018

Identifiers

DOI

10.1111/2049-632X.12033

1 reference

28 August 2017

1 reference

PubMed ID

23620179